Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

dementia-2020

About Conference


About Conference

Conference Series LLC LTD welcomes each one of the members from everyplace throughout the planet to travel to the insanity gathering that is command amid October 12-13, 2020 Zurich, Switzerland. The principle subject of our meeting is "Advancements and breakthroughs within the fields of insanity analysis and Development" that covers intensive form of essentially important sessions. This meeting flow regarding enhancements within the field of insanity and about the new treatment techniques that square measure contrived by researchers to treat completely different maladies in less hard-to-please approach. This meeting goes concerning as a best stage for participants to search out concerning this pattern in insanity innovative work.

Dementia gathering can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfill, organize, and see new logical advancements. The 2 days gathering incorporates symposiums and exceptional keynote sessions semiconductor diode by notable and eminent speakers WHO exceed expectations within the field of insanity This Worldwide insanity Meeting likewise energizes the dynamic support of young understudies, forthcoming specialists and growing researchers as we have a tendency to square measure facilitating Poster Award Competition and Young analysis Forum at the gathering setting.

Why to attend?

According to United Nations agency 47.5 million folks have dementedness and each year 7.7 million new cases square measure showing. By 2030 total cases of dementia is projected to be 75.6 million and virtually triple by 2050 to one hundred thirty-five.5 million. Alzheimer’s sickness contributes 60-70 you look after cases in dementia and second commonest condition of dementedness is tube-shaped structure dementia that contributes 2 hundredth of cases everywhere the globe. Total calculable price of dementedness is 818 billion U.S.A. $ in 2015.

A great chance to network together with your peers from academe and business. At the dementia conferences and from the eminent folk’s speech, you'll update your data concerning current of dementia analysis and receive name recognition at this 2-day event. World-renowned speakers, the foremost recent techniques, tactics, and the newest updates in dementia fields square measure hallmarks of this conference.

Significance and scope?

 Nearly 90% of the world’s population, suffer from Neurological disorders, from Alzheimer and Parkinson disease, strokes, multiple sclerosis and epilepsy to migraine, brain injuries and neuroinfections, with some 6.8 million dying each year.

Highlights:

  • Managing Dementia
  • Care Practice and Awareness
  • Alzheimer’s Disease Imaging
  • Causes and Prevention of Alzheimer’s
  • Alzheimer’s Disease Diagnosis and Symptoms
  • Alzheimer’s Disease Pathophysiology and Disease Mechanisms
  • Neurodegenerative Diseases
  • Vascular Dementia
  • Frontotemporal dementia
  • Brain Diseases
  • Anxiety & Depression
  • Drug Development in Dementia
  • Alzheimer’s Clinical Trials and Studies
  • Therapeutic Targets and Mechanisms for Treatment
  • Animal Models and Translational Medicine
  • Recent Studies & Case Reports

Target Audience:

  • Neurologists and Executives
  • Physicians
  • Neuroscientists
  • Specialists
  • Researchers
  • Health mind experts
  • Professors
  • Industrial Specialists
  • Neurosurgeons
  • Psychiatrist
  • Nutritional Researchers
  • Lecturers and Understudies from the scholarly world in the investigation of Dementia
  • Students from the scholarly community in the examination of Neurology

Attending Benefits:

  • Meet Experts from World wide
  • Face to face interaction
  • Networking Opportunities
  • Expand your ideas
  • New Tips & Tactics
  • Grow your professional network

Who should sponsor/exhibit:

  • Pharmaceuticals
  • Drug Manufacturers
  • Hospitals
  • Educational Institutes
  • Research Centres
  • Associations
  • Societies
  • Dementia Care Centres

Scientific Sessions

Track 1: Dementia

Dementia is that the term accustomed describes the symptoms of many conditions that touching the brain. The normally seen condition is Alzheimer’s, and alternative includes brain disease. Symptoms seen at early stages square measure temperament changes, withdrawal, state of mind, confusion and apathy. Early diagnosing helps with providing early treatment, support and designing. Medications would possibly facilitate with some symptoms of insanity, however no permanent cure.

Majority of individuals with insanity square measure higher than age sixty-five, the condition isn't traditional for all older people. The prevalence of insanity gets high with age, however it’s not if an older person can develop it. Whereas solely 1-in-4 people with Alzheimer’s sickness or insanity has been diagnosed. Few additional things we'd like to grasp regarding tube insanity, insanity with lewy bodies, Fronto-temporal insanity, Rarer causes of insanity, brain disorder, HIV-related psychological feature impairment, delicate psychological feature impairment.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 2: Care Practice and Awareness

Persons with dementia have multiple psychological feature deficits that embody every memory impairment, that affects the flexibleness to seek out new data or recall data antecedently learned, and one or extra of the next symptoms-aphasia, apraxia, agnosia, or government dysfunction-such that the psychological feature deficits negatively have an impression on social or activity functioning with a giant decline in previous skills. to boot, persons with dementia generally suffer from comorbid conditions that extra complicate care and impede best outcomes. Therefore, developing caregiving ways individuals with dementia is pressing, given this increasing prevalence and so the associated burden that dementia places not solely on the people, but on the caregivers, relations, and so the resources of the health care system. standard views relating geriatric nursing generally paint a picture of the care as being slow paced sure and fewer hard than acute care. However, care of the aged, and significantly those with dementia, is sometimes difficult, unpredictable, and unstable.

This session includes education and coaching of medical professionals, care and quality of life, Person focused care, psychological feature coaching, Support and coaching for casual and skilled careers, putt knowledge domain into apply, Non-pharmacological Interventions, practical foods, and art, music and life vogue.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 3: Alzheimer’s disease

Alzheimer's disease is the most common cause of dementia among older adults that usually starts slowly and worsens over time. The most common early symptom is difficulty in remembering recent events short-term memory loss. By the final stage of Alzheimer’s, damage is widespread, and brain tissue gets shrunk significantly. As the disease advances, symptoms can include problems with language, mood swings, loss of motivation, not managing self-care, and behavioural issues. Gradually, bodily functions are lost, ultimately leading to death.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 4: Alzheimer’s disease Imaging

Scientists inspect the brain’s gray substance once work regarding Alzheimer’s disease. A contemporary study found that degenerating nervous tissue within the brain can be Associate in Nursing early indicator of malady. A study was printed in Radiology that concludes that nervous tissue plays a vital role in however the disease strikes and progresses. Abnormal deposits of proteins that type amyloid plaques and letter tangles everywhere the brain in Alzheimer’s disease. It can even be characterized by shrinkage of brain tissues thanks to neurons loss.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 5: Alzheimer’s Disease Diagnosis and Symptoms

Alzheimer's is caused by nerve cell death. it's a nervous disorder during which the death of brain cells causes cognitive state and psychological feature decline. the whole size of the brain shrinks in Alzheimer's disease, nerve cells and connections within the tissue more and more reduced, that can't be seen or tested within the living brain tormented by Alzheimer's disease, post-mortem/autopsy can perpetually show small inclusions within the nerve tissues, referred to as plaques and tangles. Plaques area unit found between the dying cells within the brain - from the build-up of a super molecule referred to as beta-amyloid. The tangles exist within the brain neurons, from a disintegration of second super molecule, called tau.

Worldwide, with dementia or connected disorders nearly forty-four million individuals have suffered in 2015, past results shown 35 million population lived with dementia worldwide in year 2010, with numbers expected to just about double every twenty years, to 65.7 million in 2030 and one hundred fifteen million in 2050. In 2010, 58 per cent of all population with dementia lived in countries with lower or moderate incomes, with this proportion anticipated to rise to sixty-three until 2030 and seventy-one by 2050. This condition is anticipated to double by 2030 and quite triple by 2050 to one hundred fifteen million.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 6: Alzheimer’s Disease Pathophysiology and Mechanisms

Alzheimer’s illness may be a progressive dementia with loss of neurons and therefore the presence of 2 main microscopic neuropathological hallmarks: living thing amyloid plaques and living thing neurofibrillary tangles. Early onset AD, a rare familial kind, is caused because of mutation of 1 out of 3 genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1). noncontinuous kind happens typically when age of sixty-five and accounts for many cases; it possibly results from a mix of genetic and influence of setting. Confirmed risk factors for noncontinuous AD square measure age and therefore the presence of the E4 gene of (Apo compound protein E). Amyloid plaques comprise in the main of the toxin amide amyloid (Aβ, Abeta), cleaved consecutive from a bigger precursor super molecule (APP) by 2 enzymes: β-secretase (also known as BACE1) and γ-secretase (comprising four proteins, presenilin is one among them). If APP is 1st cleaved by the catalyst α-secretase instead of β-secretase then Aβ isn't fashioned. Neurofibrillary tangles comprise in the main of the super molecule letter that binds with microtubules that facilitating the neural transport system. letter uncoupling from tubules and aggregation into tangles inhibits transport and leads to activity of microtubule. Phosphorylation of letter may need a crucial role during this. Selective vulnerability of neural systems like the cholinergic, serotonergic, and noradrenergic and glutamatergic systems kind the idea of current rational medicine treatment.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 7: Alzheimer’s Clinical Trials and Studies

Clinical trials square measure inquired regarding examinations junction rectifier in people to decide if medicines square measure protected and viable. While not clinical analysis and the help of human volunteers, there is no higher medications, no compensatory action and no cure for Alzheimer's ill.

Clinical trials square measure often alluded to as clinical examinations; the terms square measure of utilized reciprocally, however their square measure retiring contrasts between them. Clinical trials look at new intercessions or medications to avoid, acknowledge or treat infection. A clinical report is any variety of clinical analysis together with people, paying very little heed as to if it's Associate in Nursing an intercession. Clinical examinations will likewise take a goose at totally different components of care, for instance, enhancing personal satisfaction.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 8: Therapeutic Targets and Mechanisms for Treatment

Alzheimer's illness could be a progressive neurodegenerative disease that's characterized histopathologically by the presence of plaques, principally composed of Abeta amyloid and the tangles, principally composed of hyper phosphorylated alphabetic character. To date, there's no treatment which will reverse the illness, and everyone this medical specialty is directed to address the symptoms of the illness. Here we tend to describe the efforts dedicated to attack the plaques and, in additional detail, the method of neurofibrillary degeneration, connected to the presence of the hyper phosphorylated tubule associated super molecule alphabetic character. we've known the various purported targets for medical specialty and the current data on them.

Treatment for Alzheimer's is coming into a brand new and exciting section, with many new medications starting clinical trials. several of those new therapies area unit supported our greatest current understanding of the pathologic process of Alzheimer's, and area unit designed to undertake to either slow or halt the progression of the illness. There are a unit many completely different theories underlying this effort, and these area unit in short reviewed. Therapies directed against some side of beta-amyloid formation, against neurofibrillary tangle formation and against the inflammatory response area unit all thought-about, as area unit the issues related to every space. it's nevertheless unclear that, if any of those approaches are undefeated, however the high level of activity in every of those 3 fields provides some hope that a good treatment for Alzheimer's is on the horizon.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 9: Animal Models and Translational Medicine

Animal models for Alzheimer’s illness it's vital to trust the human makeup and what's being sculptural in terms of the animal makeup. The moderator, Bradley Hyman, academic of neurology at Harvard grad school, that animal models of Alzheimer’s illness, supported the genetic science of the illness and the closely connected frontotemporal dementedness, replicate a minimum of a number of the pathology. Researchers are eminent at modeling terribly specific aspects of Alzheimer’s illness within the mouse (e.g., plaques, tangles). though these area unit incomplete models of the human illness, they need been well received within the field as doubtless relevant models to be used in drug discovery.

Patients with Alzheimer’s illness can show each amyloidopathy and tauopathy; but scientists usually focus, in a very theory approach, on one or the opposite in Associate in Nursing animal model. A participant value-added that although the anatomy within the mouse is totally different than the human, mutant letter of the alphabet mice area unit comparatively sensible models in this they recapitulate tau-dependent neurodegeneration. This has crystal rectifier several corporations to specialize in antibodies that block tau-dependent neurodegeneration in these mouse models.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 10: Recent Studies & Case Reports

Dementia may be a progressive, irreversible decline in noesis that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementedness has many etiologies of that Alzheimer’s sickness (AD) is that the most typical.

Drug development in AD is predicated on evolving pathophysiological theory. sickness modifying approaches embrace the targeting of amyloid process, aggregation of alphabetic character, endocrine signal, neuro-inflammation and neurochemical pathology, with efforts to date yielding abandoned hopes and current promise. reflective its dominance on the pathophysiological stage the amyloid cascade is central to several of the rising drug therapies.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 11: Neurodegenerative Diseases

Neurodegenerative diseases incorporate wide selection of disorders, characterized by the progressive degeneration or death of nerve cells. It affects animal tissue and causes completely different psychological science manifestations furthermore. it's Associate in Nursing umbrella term for a variety of conditions that notably influence the neurons within the human brain.

Genetic and environmental factors are shown to play an important role within the development of neurodegenerative diseases. Age is one in every of the key risk factors that's common between every type of neurodegenerative unwellness because it progresses at older ages ordinarily.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 12: Vascular Dementia

Vascular Dementia, otherwise known as multi-infarct dementia is that the second most elementary reason for insanity in additional seasoned people. Since it's a lower profile than Alzheimer's disease, several people do not speculate tube-shaped structure insanity once neglect finally ends up perceptibly venturous. It's to boot exhausting to research therefore it's exhausting to grasp exactly what variety of people expertise the sick effects of tube-shaped structure insanity. Current evaluations credit 15 August 1945 to twenty of insanity cases in additional established grown-ups to tube-shaped structure dementia. tube-shaped structure dementia happens once vessels that offer blood to the neural structure finally end up perceptibly blocked or restricted. Strokes happen once the provision of blood transference O to the mind is suddenly interrupt. Be that because it might, not all people with stroke can produce tube-shaped structure insanity. tube-shaped structure insanity will happen when your time as "noiseless" strokes collect. Frequently, tube-shaped structure dementia attracts regard for itself simply once the impact of such several strokes suggests that noteworthy handicap. Staying faraway from and dominant danger factors, for instance, diabetes, high blood pressure, smoking, and elevated steroid alcohol will facilitate check the danger of tube-shaped structure dementia.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 13: Frontotemporal dementia

Frontotemporal dementia is an uncommon type of dementia that affect the frontal and temporal lobes of the brain. These areas of the brain are generally associated with personality, behavior and language. Frontotemporal dementia is often misdiagnosed as a psychiatric problem or as Alzheimer's disease. But frontotemporal dementia tends to occur at a younger age than does Alzheimer's disease. Frontotemporal dementia often begins between the ages of 40 and 65.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 14: Parkinson Disease

Parkinson's disease is a neurodegenerative disorder that slowly damages the central nervous system. The cells that make dopamine die in a part of the brain. Nearly one million people in the US are living with Parkinson's disease. The cause is unknown, and although there is presently no cure, there are treatment options such as medication and surgery to manage its symptoms.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 15: Brain Diseases

The brain is the control center of the body, which includes the spinal cord and a large network of nerves and neurons. It controls thoughts, memory, speech, and movement. It regulates the function of many organs. When the brain is healthy, it works quickly and automatically. However, when problems occur, the results can be devastating. Brain disease includes any conditions or disabilities that affect your brain. This includes those conditions that are caused by illness, genetics, or traumatic injury.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Track 16: Anxiety & Depression

Anxiety and depression is a psychological condition or mental health disorder that interfere in one’s daily life activities like lack of interest in work, hobbies, and doing things he or she normally enjoys. Some people may lack energy, have difficulty sleeping or sleep more than usual, while some people feel anxious or irritable and find it hard to concentrate.

Related Dementia Conferences | Alzheimer Conferences | Dementia Care Conferences | Vascular Dementia Conferences | Neuroscience Conferences | Neurology Conferences | Lewy Bodies Dementia Conferences | Dementia Treatment Conferences | Dementia Conferences 2020 | Neuro Pharmacology Conferences | Neuro Surgery Conferences | Sleep Disorder Conferences | CNS Disorder Conferences | Neuro Toxicology Conferences | Neuro Immunology Conferences | Dementia Conferences 2020 USA | Dementia Conferences 2020 Europe | Dementia Conferences 2020 Asia | Brain Disorder Conferences

Alzheimer Association & Societies around the Globe

  • Alzheimer's Australia
  • Albanian Alzheimer Society
  • Association de Lucha contra el Mal de Alzheimer
  • Foundation Alzheimer Aruba (FAA)
  • Alzheimer Austria
  • Alzheimer Support Group
  • Alzheimer Society of Bangladesh
  • Barbados Alzheimer's Association Inc.
  • Alzheimer’s and Dementia Association of The Cayman Islands
  • Ligue National Alzheimer Liga
  • Alzheimer's Family Support Group
  • Association Bolivian de Alzheimery Otras Dementias
  • FEBRAZ - Federico Brasilia de Associaçãoes de Alzheimer
  • Corporation Alzheimer Chile
  • Alzheimer's disease Chinese
  • Alzheimer Association & Societies in Canada

 Hospital Associated with Dementia:

  • SBCC Baby & Child Clinic (Neurology Centre)
  • Tang Neurology & Medical Clinic
  • Vision 2 Engineering Pte. Ltd
  • Raffles Neuroscience Centre
  • P N Chong Neurology Clinic
  • Mount Elizabeth Hospital
  • Tan Chai Beng
  • Dr Adrian Tan Keng Yew
  • Ho Neurology Pte Ltd
  • Gleneagles Hospital
  • National Neuroscience Institute
  • National University Hospital

Products manufactured by the industries:

Three drugs are available to treat symptoms in people with Mild to moderate Alzheimer’s disease

Aricept™ produced by Pfizer Canada Inc.,

Exelon™ produced by Novartis Pharma Canada Inc.

Reminyl™ produced by Janssen Ortho Inc.

Two drugs for Moderate to advanced Alzheimer’s disease

Ebixa®

Aricept™

To Collaborate Scientific Professionals around the World

Conference Date October 12-13, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

Journals of Alzheimers Disease and Parkinsonism Journal of Neurological Disorders Brain Disorders and Therapy

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by